Eloxatin and Prednisolone drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Eloxatin (oxaliplatin) and Prednisolone (prednisolone). Common drug interactions include arteriospasm coronary among females and death among males.

The phase IV clinical study analyzes what interactions people have when they take Eloxatin and Prednisolone. It is created by eHealthMe based on reports of 25 people who take the same drugs from the FDA, and is updated regularly.

What is Eloxatin?

Eloxatin has active ingredients of oxaliplatin. eHealthMe is studying from 7,092 Eloxatin users. Check the latest studies of Eloxatin.

What is Prednisolone?

Prednisolone has active ingredients of prednisolone. It is often used in rheumatoid arthritis. eHealthMe is studying from 212,675 Prednisolone users. Check the latest studies of Prednisolone.



On Jul, 12, 2026

25 people who take Eloxatin and Prednisolone together, and have interactions are studied.

Eloxatin and Prednisolone drug interactions.

What are the common drug interactions of Eloxatin and Prednisolone, by gender? *:

female:

  1. Arteriospasm coronary (spasm of the large- or medium-sized coronary arteries)
  2. Arrhythmia supraventricular (irregular heartbeat supraventricular origin)
  3. Blood disorder
  4. Blood pressure ambulatory increased
  5. Concussion (short loss of normal brain function in response to a head injury)
  6. Infection
  7. Proteinuria (presence of protein in the urine)
  8. Syncope (loss of consciousness with an inability to maintain postural tone)
  9. Ventricular arrhythmia (problem with the rate or rhythm of the heartbeat)
  10. Blood pressure increased

male:

  1. Death
  2. Dyspnoea (difficult or laboured respiration)
  3. Renal failure (kidney dysfunction)
  4. Transient ischaemic attack (a transient episode of neurologic dysfunction caused by ischemia (loss of blood flow))
  5. Acute myocardial infarction (acute heart attack)
  6. Arthralgia (joint pain)
  7. Cyanosis (lack of oxygen in body leads to blue appearance of skin ,mucous membrane nails)
  8. Dizziness
  9. Fatigue (feeling of tiredness)
  10. Headache (pain in head)

What are the common drug interactions of Eloxatin and Prednisolone, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Renal failure acute (rapid kidney dysfunction)
  2. Septic shock (shock due to blood infection)

30-39:

n/a

40-49:

  1. Dyspnoea (difficult or laboured respiration)

50-59:

  1. Arteriospasm coronary (spasm of the large- or medium-sized coronary arteries)
  2. Arrhythmia supraventricular (irregular heartbeat supraventricular origin)
  3. Ventricular arrhythmia (problem with the rate or rhythm of the heartbeat)
  4. Acute myocardial infarction (acute heart attack)
  5. Death
  6. Dizziness
  7. Dyspnoea (difficult or laboured respiration)
  8. Fatigue (feeling of tiredness)
  9. Headache (pain in head)
  10. Hepatocellular damage (liver damage)

60+:

  1. Blood disorder
  2. Blood pressure ambulatory increased
  3. Neoplasm progression (growth of tumour)
  4. Neuropathy peripheral (surface nerve damage)
  5. Renal failure (kidney dysfunction)
  6. Transient ischaemic attack (a transient episode of neurologic dysfunction caused by ischemia (loss of blood flow))
  7. Arthralgia (joint pain)
  8. Blood pressure increased
  9. Cyanosis (lack of oxygen in body leads to blue appearance of skin ,mucous membrane nails)
  10. Tremor (trembling or shaking movements in one or more parts of your body)

What are the existing conditions these people have? *

  1. Colon Cancer: 14 people, 56.00%
  2. Nausea (feeling of having an urge to vomit): 3 people, 12.00%
  3. Pain: 2 people, 8.00%
  4. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 2 people, 8.00%
  5. Cholangiocarcinoma (a cancer that forms glands or secretes significant amounts of mucins): 2 people, 8.00%
  6. Asthma: 2 people, 8.00%

* Approximation only. Some reports may have incomplete information.

Do you take Eloxatin and Prednisolone?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Eloxatin and Prednisolone:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Eloxatin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Prednisolone:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Eloxatin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Prednisolone and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on oxaliplatin and prednisolone (the active ingredients of Eloxatin and Prednisolone, respectively), and Eloxatin and Prednisolone (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: